Bone and heart abnormalities of subclinical hyperthyroidism in women below the age of 65 years

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 52, Issue 9, 2008, Pages 1448-1451

  Rosario, Pedro Weslley ^a,b  

^a Endocrinology Service   (Brazil)

^b Centro de Estudos e Pesquisa da Clinica de Endocrinologia e Metabologia CEPCEM   (Brazil)

Author keywords

Bone; Heart; Subclinical hyperthyroidism

Indexed keywords

THYROTROPIN;

ADULT; ARTICLE; BONE DENSITY; CASE CONTROL STUDY; FEMALE; FEMUR NECK; HEART DISEASE; HUMAN; HYPERTHYROIDISM; METABOLIC BONE DISEASE; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; POSTMENOPAUSE; PREMENOPAUSE; RADIOGRAPHY;

ADULT; BONE DENSITY; BONE DISEASES, METABOLIC; CASE-CONTROL STUDIES; FEMALE; FEMUR NECK; HEART DISEASES; HUMANS; HYPERTHYROIDISM; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; STATISTICS, NONPARAMETRIC; THYROTROPIN;

EID: 60149084826     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302008000900007     Document Type: Article

References (9)

1. Cooper DS. Approach to the patient with subclinical hyperthyroidism. J Clin Endocrinol Metab. 2007;92:3-9.
2. Biondi B, Palmieri EA, Fazio S, Cosco C, Nocera M, Saccà L, et al. Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. J Clin Endocrinol Metab. 2000;85:4701-5.
3. Devereux RB, Lutas EM, Casale PN, Kligfi eld P, Eisenberg RR, Hammond IW, et al. Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol. 1984; 4:1222-30.
4. Sgarbi JA, Villaça FG, Garbeline B, Villar HE, Romaldini JH. The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism in clinical and heart abnormalities. J Clin Endocrinol Metabol. 2003;88:1672-7.
5. Schlote B, Schaaf L, Schmidt R, Pohl T, Vardarli I, Schiebeler H, et al. Mental and physical state in subclinical hyperthyroidism: investigations in a normal working population. Biol Psychiatry. 1992;32:48-56.
6. Petretta M, Bonaduce D, Spinelli L, Vicario ML, Nuzzo V, Marciano F, et al. Cardiovascular haemodynamics and cardiac autonomic control in patients with subclinical and overt hyperthyroidism. Eur J Endocrinol. 2001;145:691-6.
7. Tauchmanovà L, Nuzzo V, Del Puente A, Fonderico F, Esposito-Del Puente A, Padulla S, et al. Reduced bone mass detected by bone quantitative ultrasonometry and DEXA in pre- and postmenopausal women with endogenous subclinical hyperthyroidism. Maturitas. 2004;48:299-306.
8. Foldes J, Tarjan G, Szathmary M, Varga F, Krasznai I, Horvath C. Bone mineral density in patients with endogenous subclinical hyperthyroidism: is the thyroid status a risk factor for osteoporosis? Clin Endocrinol (Oxf). 1993;39:521-7.
9. Gurlek A, Gedik O. Effect of endogenous subclinical hyperthyroidism on bone metabolism and bone mineral density in premenopausal women. Thyroid. 1999;9:539-43.